Day: May 25, 2022

All director nominees elected and all matters before the Stockholders approved DENVER, May 25, 2022 (GLOBE NEWSWIRE) — Akerna Corp. (Nasdaq: KERN) (“Akerna”) announced today the results of its reconvened 2022 annual meeting of stockholders (the “Annual Meeting”) held Wednesday, May 25, 2022 at 9 a.m. Mountain Time with respect to all proposals described in Akerna’s definitive proxy statement filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 19, 2022 (the “Proxy Statement”). A total of 23,353,671 shares of common stock of the Company were represented at the Annual Meeting being approximately 67% of the outstanding voting securities of the Company as of the record date for the Annual Meeting on March 31, 2022 and representing a quorum for the conduct of business at the Annual Meeting. At the Annual Meeting,...

Follows Previous Recommendation from Glass Lewis in Support of ALL Proposals Recommends Shareholders Vote “FOR” Both of MIMEDX’s Highly Qualified Director Nominees – James L. Bierman and Phyllis Gardner, M.D. Recommends Shareholders Vote “FOR” the Company’s Say-on-Pay Proposal and the Qualified Employee Stock Purchase Plan MARIETTA, Ga., May 25, 2022 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the “Company”) today announced that leading proxy advisory firm Institutional Shareholder Services (“ISS”) has recommended that shareholders vote “FOR ALL” of the Company’s proposals including “FOR” both of MIMEDX’s director nominees – James L. Bierman and Phyllis Gardner, M.D. – on the WHITE proxy card at its 2022 Annual Meeting of Shareholders scheduled for Tuesday, June 7, 2022 at 9:00 a.m. Eastern Time, which will...

Fairport, NY, May 25, 2022 (GLOBE NEWSWIRE) — Vinco Ventures, Inc. (NASDAQ:BBIG), a digital media and content technologies holding company (“Vinco Ventures,” “Vinco,” or the “Company”), today announced that, due to contractual and regulatory conditions, the Company’s Board of Directors has decided to delay the distribution date for the previously announced spin-off of Cryptyde, Inc. (“Cryptyde”). On May 5, 2022, the Company announced that each Vinco stockholder of record as of the close of business on May 18, 2022 would receive one share of Cryptyde common stock for every ten shares of Vinco common stock held and that such share dividend was expected to be distributed on or about May 27, 2022. The Company currently expects the distribution date for the Cryptyde spin-off to occur on or about the end of the second quarter of 2022,...

Company announcement – No. 23 / 2022 Zealand Pharma launches long-term incentive program for Zealand’s Corporate Management and employees for 2022 Copenhagen, DK and Boston, MA, May 25, 2022 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces the implementation of an updated long-term incentive program (the “LTIP”) for Zealand’s Corporate Management and employees in accordance with Zealand’s Remuneration policy and overall guidelines for incentive pay, as adopted at the annual general meeting held on April 6, 2022. Long-term incentive programZealand has awarded 266,223 performance stock units (“PSUs”), 99,420 restricted stock units (“RSUs”) and 863,156 warrants to Corporate...

MALVERN, Pa., May 25, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurological health disorders, today announced that Keith Sullivan, President and Chief Executive Officer, and Steve Furlong, Senior Vice President, Chief Financial Officer, and Treasurer will present at the William Blair 42nd Annual Growth Stock Conference. The Company is scheduled to present on Wednesday, June 8, 2022 at 2:20pm ET. A live audio webcast of the presentation will be available online at the investor relations page of the Company’s website at ir.neuronetics.com. A replay of the webcast will be archived on the website for approximately 90 days. About Neuronetics Neuronetics,...